Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target

Transl Lung Cancer Res. 2024 Mar 29;13(3):689-693. doi: 10.21037/tlcr-23-754. Epub 2024 Mar 15.

Authors

Kazutaka Hosoya¹, Hiroaki Ozasa¹

Affiliation

¹ Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

No abstract available

Keywords: B-cell/CLL lymphoma 2 (BCL-2); Small-cell lung cancer (SCLC); apoptosis; aurora kinase B (AURKB).

Publication types

Editorial
Comment